🇺🇸 FDA
Patent

US 10703735

4-phenyl-coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer

granted A61KA61K31/37A61K31/381

Quick answer

US patent 10703735 (4-phenyl-coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer) held by Lead Discovery Center GmbH expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Lead Discovery Center GmbH
Grant date
Tue Jul 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/37, A61K31/381, A61K31/4025, A61K31/4433